WPN Chameleon create visual identity for new charity partnership, Connect Immune Research
By Lucy Tugby05/12/2018
London, 8 November, 2018: Creative agency WPN Chameleon (WPNC) has developed a visual identity for newly formed charity partnership, Connect Immune Research that will work to promote a collaborative approach to autoimmune conditions research.
Founded by JDRF, Versus Arthritis, MS Society and with the support of the British Society for Immunology, the Connect Immune Research partnership will raise awareness and drive forward research that works across a wide range of autoimmune conditions, targeting medical research bodies, the scientific community, fundraising bodies, corporate partners and charity supporters.
John Eversley, MD at WPNC commented, “We were honoured to be asked to work on bringing this new collaboration to life, with such an important remit for the future of autoimmune research”.
Orna Joseph, Head of Brand and Marketing of type 1 diabetes charity JDRF, said:
“Autoimmune conditions involve the immune system acting inappropriately, so we know they are connected. But researchers investigating different autoimmune conditions are not. Until now they have largely worked separately, focused on the specific conditions rather than the interconnected factors of autoimmunity.”
“WPNC appreciated and understood the significance of this collaboration and brought it to life for us. The new identity will greatly help the partnership to connect with its multiple audiences.”
WPN Chameleon is a strategic Campaign Top 40 creative agency dedicated to achieving better results in digital, DRTV, social, web design/build, direct mail, press, inserts and integrated campaigns. Our experienced team of 55 across insight, creative, and technical has an enviable record of delivering high-performance marketing communications for both commercial and non-profit clients. www.wpnchameleon.co.uk.
JDRF is the leading global organisation funding type 1 diabetes research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications. To accomplish this, JDRF has invested more than £1 billion since our inception. We collaborate with the most talented minds to develop and deliver a pipeline of innovative therapies to people living with type 1 diabetes. Our staff and volunteers around the globe are dedicated to campaigning for our vision of a world without type 1 diabetes. For more information, please visit jdrf.org.uk or follow us on Twitter: @JDRFUK.